Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deal Watch: Amgen Outsources Celiac Drug To Provention; Lilly, NextCure Will Co-Discover IO Drugs

Executive Summary

Through its Provention collaboration, Amgen partnered with the team that worked on AMG 714 at Celimmune, which the big biotech bought in 2017. Lilly will partner with NextCure to use the latter's FIND-IO platform for immuno-oncology drug discovery.

Advertisement

Related Content

Finance Watch: Investment In Novel Antibacterials Gets A New Boost With Qpex Launch
Finance Watch: Summer Heat Extends To Biopharma IPOs With Nine In July, 45 This Year
$1.6bn ARMO Buy Gives Lilly Its Most Advanced Immuno-Oncology Asset
KemPharm And The Curious Case Of Launching A Brand Opioid Like A Generic
Melinta Expands Portfolio, TMC Narrows Focus To LDL Reduction With Anti-Infective Deal
KemPharm Plans To License Out Commercial Rights For Pain, ADHD Candidates
Provention Builds On J&J Disease Interception Model
Immuno-Oncology Startup Snatches $67m In Series A
BioNotebook: Denovo, Celimmune revive Lilly, Amgen programs; Malin invests in Serenus; J&J opens fourth incubator; Blueprint, Alexion partner
Aeterna Zentaris tanks on FDA Macrilen rejection

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC124142

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel